Multimodal Large Language Models for Prognostic Prediction in Cervical Cancer Treated with Definitive Chemoradiotherapy: An Exploratory Study of Systematic Multimodal Data Integration
Assessment of whether a general-purpose Multimodal large language model could both generate a structured report from pelvic MRI images and combine clinical, laboratory, treatment and imaging data to estimate recurrence risk found it was often discordant in specific and clinically important ways.
Abstract
Simple Summary About a quarter to a third of women treated with definitive chemoradiotherapy for cervical cancer eventually relapse; therefore, identifying higher-risk patients early would help individualize treatment intensity and follow-up. Multimodal large language models can read images and text together and reason over many kinds of clinical data without being trained for the specific task. In 82 patients, we assessed whether one such general-purpose model (Gemini 3.1 Pro) could both generate a structured report from pelvic MRI images and combine clinical, laboratory, treatment and imaging data to estimate recurrence risk. Supplying an MRI report improved the prediction, and the best setup reached an AUC of approximately 0.79, though this specific gain over clinical data alone held on our primary statistical test but not on a secondary sensitivity check. When we checked the model’s own MRI reports against the radiologists’ reports, however, they were often discordant in specific and clinically important ways—overcalling parametrial invasion relative to the radiologist’s report and being unable to assess lymph nodes. Therefore, they are not yet safe to use without oversight. We report the pipeline and its baseline results for others to build upon.
These findings should be interpreted cautiously because area under the receiver operating characteristic curve (AUC) alone does not establish clinical utility, and Prospective, multicentre validation studies reporting sensitivity, specificity, predictive values, likelihood ratios, calibration, and decision curve analys...
Yun-Lin Luo, You-Ping Ding, Wei Liu et al.· Cancers· 0 citations
PURPOSE
Pretreatment estimation of pathological complete response (pCR) to neoadjuvant chemotherapy may support risk stratification and future response-adapted clinical studies in breast cancer. However, existing deep learning approaches often rely on "black-box" visual pattern recognition, suffering from poor interpre...
Prediction of pathological complete response (pCR) in breast cancer is relevant for clinical decision making and individual risk assessment, but remains challenging at present. This study aimed to design and validate clinically-informed, interpretable dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) frame...
B. N. Prathibha, Rashmi P. Karchi· Computer and Decision Making...· 0 citations
To develop, as a proof-of-concept analysis, a machine learning model predicting early radiological treatment response in an elderly, single-center esophageal cancer (EC) cohort, and to test whether adding clinical factors to CT radiomics improves prediction.
We retrospectively reviewed 189 patients with EC...
Qing Zhou, Zhen-Chao Tao, Hong-Bo Zhang et al.· BMC Medical Imaging· 0 citations
Simple Summary Neuroendocrine carcinoma of the cervix is a rare, aggressive cancer. Knowing whether it has spread to lymph nodes helps guide treatment, but routine scans can miss this spread. We studied 133 patients from two hospitals to assess whether computer analysis of magnetic resonance imaging (MRI) scans could e...
Jian Chen, Feng-Le Jiang, Xing-Fa Chen et al.· Current Oncology· 0 citations